A 24-Week Randomized, Doubleblinded Multicenter Active Controlled (Pioglitazone) Study to Evaluate the Efficacy Safety and Tolerability of Tesaglitzar Therapy

  • Reynolds, L (PI)
  • Anderson, James (CoI)
  • Karounos, Dennis (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date9/27/04 → 3/31/06